Phospho-CTBP1 (Ser422) Antibody

What is CTBP1 and why is phosphorylation at Ser422 biologically significant?

CTBP1 (C-terminal binding protein 1) functions as a transcriptional corepressor that plays important roles in cellular processes including development, oncogenesis, and apoptosis. The phosphorylation at Serine 422 represents a post-translational modification that can alter CTBP1's function, localization, or interactions with other proteins. This specific phosphorylation has been observed in response to TNF treatment as demonstrated in Western blot analyses of Jurkat cell extracts, suggesting its involvement in inflammatory response pathways . The phosphorylation site is located within the sequence motif A-P-S-P-G in human CTBP1, which appears to be a regulatory region of the protein that affects its biological activity.

What are the key applications for Phospho-CTBP1 (Ser422) Antibody?

The Phospho-CTBP1 (Ser422) Antibody has been validated for several experimental applications:

• Western Blotting (WB): Using dilutions of 1:500-1:1000 for detecting phosphorylated CTBP1 in cell and tissue lysates

• Immunohistochemistry (IHC): Using dilutions of 1:50-1:100 for analyzing tissue sections

• ELISA: For quantitative detection of phosphorylated CTBP1 levels

The antibody specifically detects endogenous levels of CTBP1 only when phosphorylated at serine 422, making it valuable for studying signaling pathways that regulate this phosphorylation event .

What species reactivity does this antibody demonstrate?

The Phospho-CTBP1 (Ser422) Antibody has been validated to react with phosphorylated CTBP1 from multiple species:

• Human

• Mouse

• Rat

This cross-reactivity makes the antibody useful for comparative studies across different model organisms commonly used in biomedical research .

What are the optimal storage conditions for maintaining antibody activity?

The Phospho-CTBP1 (Ser422) Antibody should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of antibody function. The antibody is supplied in a stabilizing solution of phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150mM NaCl, 0.02% sodium azide, and 50% glycerol. This formulation helps maintain antibody stability during long-term storage. When properly stored, the antibody maintains activity for approximately one year .

What controls should be included when using this antibody in experiments?

When designing experiments with the Phospho-CTBP1 (Ser422) Antibody, several controls should be included:

The validation data shows that pre-incubation with the immunizing phospho-peptide blocks antibody binding in both Western blotting and immunohistochemistry applications, confirming the specificity of the antibody for the phosphorylated epitope .

How can I validate that my antibody specifically detects CTBP1 phosphorylated at Ser422?

To validate the phospho-specificity of the antibody:

• Prepare paired samples where one set is treated with lambda phosphatase to remove phosphorylation

• Run both treated and untreated samples on Western blot

• Probe with the Phospho-CTBP1 (Ser422) Antibody

• Signal should diminish or disappear in phosphatase-treated samples

• Perform peptide competition assays using:

  • The phosphorylated peptide (should block signal)

  • The non-phosphorylated version of the same peptide (should not block signal)

• Compare results with total CTBP1 antibody to confirm target protein identity

The antibody's specificity has been confirmed through detailed purification processes including affinity chromatography using epitope-specific phosphopeptide and removal of non-phospho-specific antibodies through chromatography using non-phosphopeptide .

What is the recommended protocol for Western blotting with this antibody?

For optimal Western blotting results with Phospho-CTBP1 (Ser422) Antibody:

• Sample preparation:

  • Lyse cells in buffer containing phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate)

  • Denature proteins in SDS sample buffer at 95°C for 5 minutes

• SDS-PAGE and transfer:

  • Resolve 20-40 μg protein per lane on 10-12% SDS-PAGE

  • Transfer to PVDF or nitrocellulose membrane

• Blocking and antibody incubation:

  • Block membrane in 5% BSA in TBST for 1 hour at room temperature

  • Incubate with Phospho-CTBP1 (Ser422) Antibody at 1:500-1:1000 dilution overnight at 4°C

  • Wash 3 times with TBST, 5 minutes each

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

  • Wash 3 times with TBST, 5 minutes each

• Detection:

  • Develop using ECL substrate

  • Expected molecular weight: approximately 48 kDa

The validation images show specific detection of phosphorylated CTBP1 in TNF-treated Jurkat cells with clear signal reduction when competing with the specific phospho-peptide .

What protocol modifications are recommended for immunohistochemistry applications?

For immunohistochemistry with Phospho-CTBP1 (Ser422) Antibody:

• Tissue preparation:

  • Fix tissues in 10% neutral buffered formalin

  • Embed in paraffin and section at 4-6 μm thickness

• Deparaffinization and antigen retrieval:

  • Deparaffinize sections through xylene and graded alcohols

  • Perform heat-mediated antigen retrieval in citrate buffer (pH 6.0) for 15-20 minutes

  • Cool to room temperature and wash in PBS

• Blocking and antibody incubation:

  • Block endogenous peroxidase with 3% H₂O₂ in methanol for 15 minutes

  • Block non-specific binding with 5% normal goat serum for 1 hour

  • Incubate with Phospho-CTBP1 (Ser422) Antibody at 1:50-1:100 dilution overnight at 4°C

  • Wash 3 times with PBS, 5 minutes each

• Detection:

  • Apply HRP-conjugated secondary antibody for 1 hour at room temperature

  • Develop with DAB substrate

  • Counterstain with hematoxylin, dehydrate, and mount

Validation data shows specific nuclear staining in human brain tissue sections that is completely abolished when the antibody is pre-incubated with the phospho-peptide .

How can I induce CTBP1 phosphorylation at Ser422 in experimental models?

Based on the validation data, TNF (Tumor Necrosis Factor) treatment effectively induces phosphorylation of CTBP1 at Ser422 in Jurkat cells. A recommended protocol would be:

• Culture Jurkat cells in complete RPMI medium with 10% FBS

• When cells reach approximately 70-80% confluence, treat with:

  • TNF-α at 10-50 ng/ml

  • Incubate for 15-30 minutes at 37°C

• Harvest cells and prepare lysates in buffer containing phosphatase inhibitors

• Analyze by Western blotting using the Phospho-CTBP1 (Ser422) Antibody

This model can be adapted to study signaling pathways involving CTBP1 phosphorylation in response to inflammatory stimuli .

How does CTBP1 phosphorylation at Ser422 relate to its cellular functions?

CTBP1 functions primarily as a transcriptional corepressor that recruits histone deacetylases and other chromatin-modifying enzymes to repress gene expression. Phosphorylation at Ser422 appears to be induced by TNF signaling, suggesting potential roles in:

• Inflammatory response regulation

• Modulation of transcriptional repression activity

• Alteration of protein-protein interactions

• Changes in subcellular localization

The specific phosphorylation at Ser422 likely represents a regulatory mechanism by which CTBP1's corepressor function is modulated in response to cellular signaling. The nuclear localization observed in the IHC images suggests that phosphorylated CTBP1 maintains its nuclear function, potentially with altered activity or binding partners .

What are the best approaches for studying CTBP1 phosphorylation dynamics?

To investigate dynamic changes in CTBP1 phosphorylation at Ser422:

• Time-course experiments:

  • Treat cells with stimulus (e.g., TNF) for various time points (5, 15, 30, 60 minutes)

  • Analyze phosphorylation levels by Western blotting

  • Plot the kinetics of phosphorylation and dephosphorylation

• Phosphatase inhibitor studies:

  • Treat cells with various phosphatase inhibitors to identify enzymes responsible for dephosphorylation

  • Options include okadaic acid (PP2A inhibitor), calyculin A (PP1 inhibitor), or broad-spectrum inhibitors

• Kinase inhibitor screening:

  • Pre-treat cells with inhibitors of various kinase families

  • Stimulate with TNF and assess which inhibitors block Ser422 phosphorylation

  • This approach can help identify the responsible kinase

• Phosphomimetic and phospho-deficient mutants:

  • Generate S422A (cannot be phosphorylated) and S422D/E (mimics phosphorylation) mutants

  • Express in cells and assess functional consequences on transcriptional activity and protein interactions

These approaches would provide comprehensive insights into the regulatory mechanisms controlling CTBP1 phosphorylation and its functional significance .

How can I use the Phospho-CTBP1 (Ser422) Antibody in combination with other techniques for more comprehensive analysis?

The Phospho-CTBP1 (Ser422) Antibody can be integrated into multimodal research approaches:

• Chromatin immunoprecipitation (ChIP):

  • Use the antibody to specifically immunoprecipitate phosphorylated CTBP1

  • Analyze associated DNA sequences to identify genes regulated by phospho-CTBP1

  • Compare results with ChIP using total CTBP1 antibody to identify phosphorylation-specific binding sites

• Co-immunoprecipitation (Co-IP):

  • Immunoprecipitate phosphorylated CTBP1 using the phospho-specific antibody

  • Identify interacting partners by mass spectrometry

  • Compare interactomes between phosphorylated and non-phosphorylated CTBP1

• Immunofluorescence microscopy:

  • Use the antibody for subcellular localization studies

  • Combine with markers for nuclear domains or other subcellular structures

  • Assess colocalization with potential interacting partners

• Proximity ligation assay (PLA):

  • Combine Phospho-CTBP1 (Ser422) Antibody with antibodies against potential interacting proteins

  • Visualize and quantify specific interactions in situ

  • Compare interaction patterns before and after stimulation

These integrated approaches can provide mechanistic insights into how phosphorylation at Ser422 regulates CTBP1 function in different cellular contexts .

What are common issues encountered when using phospho-specific antibodies and how can they be resolved?

When working with the Phospho-CTBP1 (Ser422) Antibody, researchers may encounter several challenges:

To optimize signal-to-noise ratio, researchers should carefully titrate antibody concentrations and adjust incubation times based on their specific experimental conditions .

How can I optimize immunohistochemistry protocols for different tissue types?

Different tissues may require specific optimization strategies:

• Antigen retrieval methods:

  • For brain tissue: Citrate buffer (pH 6.0) with 15-20 minutes of heat treatment

  • For highly fixated tissues: Consider stronger retrieval with EDTA buffer (pH 8.0)

  • For delicate tissues: Enzymatic retrieval with proteinase K may be gentler

• Blocking adjustments:

  • For tissues with high endogenous peroxidase: Extend H₂O₂ treatment to 20-30 minutes

  • For tissues with high background: Include additional blocking with avidin/biotin block

  • For fatty tissues: Consider additional blocking with 0.1% Triton X-100

• Antibody dilution optimization:

  • Start with the recommended 1:50-1:100 range

  • Prepare a dilution series (e.g., 1:25, 1:50, 1:100, 1:200)

  • Select optimal dilution based on signal-to-noise ratio

• Incubation conditions:

  • For difficult-to-detect phospho-epitopes: Extended incubation (up to 48 hours at 4°C)

  • For tissues with accessibility issues: Consider adding 0.025-0.1% saponin to antibody dilution

The validation data shows successful IHC staining of human brain tissue, suggesting these conditions as a starting point for brain-related research .

What strategies can be employed to confirm antibody specificity in my experimental system?

To rigorously validate the specificity of Phospho-CTBP1 (Ser422) Antibody:

• Genetic approaches:

  • CRISPR/Cas9 knockout of CTBP1

  • siRNA knockdown of CTBP1

  • Site-directed mutagenesis of Ser422 to Ala (S422A)

• Biochemical validation:

  • Lambda phosphatase treatment of samples

  • Peptide competition with phosphorylated and non-phosphorylated peptides

  • Sequential immunoprecipitation with total CTBP1 antibody followed by Western blot with phospho-antibody

• Pharmacological verification:

  • Kinase inhibitor treatment to prevent phosphorylation

  • Dose-dependent studies with stimulators like TNF

  • Time-course experiments to track phosphorylation dynamics

• Cross-validation with alternative methods:

  • Mass spectrometry to confirm phosphorylation state

  • Using a different phospho-specific antibody targeting the same site

  • Phospho-proteomic analysis to confirm changes in phosphorylation

These comprehensive approaches ensure that the observed signals truly represent phosphorylated CTBP1 at Ser422 rather than non-specific binding or cross-reactivity .

What are emerging research areas involving CTBP1 phosphorylation?

Current and future research directions involving CTBP1 phosphorylation at Ser422 include:

• Role in inflammatory signaling pathways:

  • Given the TNF-induced phosphorylation, investigating connections to NF-κB signaling

  • Potential involvement in cytokine-regulated gene expression programs

  • Implications for inflammatory diseases and immune responses

• Cancer biology applications:

  • CTBP1 has established roles in oncogenesis

  • Investigating how Ser422 phosphorylation affects its tumor-promoting or suppressing activities

  • Potential as a biomarker for certain cancer types or states

• Neuroscience research:

  • The validation in brain tissue suggests neurological relevance

  • Potential roles in neuroinflammation and neurodegenerative conditions

  • Connections to stress-responsive gene regulation in neural cells

• Development of targeted therapeutics:

  • If functionally significant, the phosphorylation site could represent a therapeutic target

  • Small molecule inhibitors of the responsible kinase

  • Peptide-based inhibitors targeting the phosphorylation site

The specific, phosphorylation-state dependent antibody provides a valuable tool for investigating these emerging research areas .

How might advanced techniques enhance our understanding of CTBP1 phosphorylation?

Cutting-edge research techniques that could advance our understanding include:

• Single-cell phospho-proteomics:

  • Analyzing cell-to-cell variability in CTBP1 phosphorylation

  • Identifying rare cell populations with distinct phosphorylation patterns

  • Correlating with single-cell transcriptomics to link phosphorylation to gene expression

• Live-cell imaging technologies:

  • Development of phospho-specific biosensors for real-time monitoring

  • FRET-based approaches to visualize phosphorylation dynamics

  • Optogenetic tools to spatiotemporally control CTBP1 phosphorylation

• Cryo-EM and structural biology:

  • Determining the structural consequences of Ser422 phosphorylation

  • Identifying conformational changes that affect protein-protein interactions

  • Structure-based design of specific modulators

• Systems biology approaches:

  • Network analysis to position CTBP1 phosphorylation within broader signaling networks

  • Mathematical modeling of phosphorylation/dephosphorylation kinetics

  • Integration with multi-omics data to establish functional consequences

These advanced technologies could provide unprecedented insights into the molecular mechanisms and biological significance of CTBP1 phosphorylation at Ser422 .